Contrary to the above-mentioned cases, Sun and colleagues described two cases of two female patients with refractory (they had previously failed anti-TNF-α therapies) pyoderma gangrenosum and HS unresponsive to canakinumab treatment [213]. Here, TNF is linked to histiocytic sarcoma.